Vitamin K status and bone health: An analysis of methods for determination of undercarboxylated osteocalcin

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 9, 1998, Pages 3258-3266

  Gundberg, Caren M ^a   Nieman, Sherril D ^a   Abrams, Steven ^b   Rosen, Harold ^c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OSTEOCALCIN; VITAMIN K GROUP;

AMINO TERMINAL SEQUENCE; ARTICLE; BONE; CARBOXYLATION; HORMONE DETERMINATION; HUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DETERMINATION; RADIOIMMUNOASSAY;

ADULT; ANTIBODIES, MONOCLONAL; ANTICOAGULANTS; BARIUM SULFATE; CHILD; DURAPATITE; FALSE POSITIVE REACTIONS; HUMANS; NUTRITIONAL STATUS; OSTEOCALCIN; PEPTIDE FRAGMENTS; QUALITY CONTROL; RADIOIMMUNOASSAY; REAGENT KITS, DIAGNOSTIC; VITAMIN K; WARFARIN;

EID: 0031792815     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.83.9.3258     Document Type: Article

References (33)

1. Stenflo J, Suttie JW. 1977 Vitamin K-dependent formation of gamma-carboxyglutamic acid. Annu Rev Biochem. 46:157-172.
2. Hodges SJ, Pilkington MJ, Stamp TCB, et al. 1991 Depressed levels of circulating menaquinones in patients with osteoporotic fractures of the spine and femoral neck. Bone. 12:387-389.
3. Rosen NH, Maitland LA, Suttie JW, Manning WJ, Glynn RJ, Greenspan S. 1993 Vitamin K and maintenance of skeletal integrity in adults. Am J Med. 94:62-68.
4. Lafforque P, Daver L, Monites JR, Chagnaud C, de Boissezon MC, Acquaviva PC. 1997 Bone mineral density in patients given oral vitamin K antagonists. Revue du Rhumatisme. 64:249-254.
5. Philip WJU, Martin JC, Richardson JM, Reid DM, Webster J, Douglas AS. 1995 Decreased axial and peripheral bone density in patients taking long-term warfarin. Q J Med. 88:635-640.
6. Monreal M, Olive A, Lafozz E, Del Rio L. 1995 Heparins, coumarin, and bone density. Lancet. 338:706.
7. Jamal S, Milani G, Lipschutz R, Stone K, Browner WS, Cummings SR. 1997 The therapeutic use of warfarin does not influence post-menopausal osteoporosis. J Bone Miner Res 12[Suppl 1]:T512.
8. Sokoll LJ, Sadowski JA. 1996 Comparison of biochemical indexes for assessing vitamin K nutritional status in a healthy adult population. Am J Clin Nutr. 63:566-573.
9. Price PA, Williamson MK, Lothringer JW. 1981 Origin of the vitamin K-dependent bone protein found in plasma and its clearance by kidney and bone. J Biol Chem. 256:12760-12766.
10. Sokoll L, O'Brien ME, Camilo ME, Sadowski JA. 1995 Undercarboxylated osteocalcin: development of a method to determine vitamin K status. Clin Chem. 41:1121-1128.
11. Szulc P, Chapuy M-C, Meunier P, Delmas P. 1993 Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. J Clin Invest. 91:1769-1774.
12. Szulc P, Arlot M, Chapuy M-C, Duboeuf F, Meunier PJ, Delmas PD. 1994 Serum undercarboxylated osteocalcin correlates with hip bone mineral density in elderly women. J Bone Miner Res. 9:1591-1595.
13. Vergnaud P, Garnero P, Meunier PJ, Bréart G, Kamihagi K, Delmas PD. 1997 Undercarboxylated osteocalcin measured with a specific immunoassy predicts hip fracture in elderly women: the EPIDOS study. J Clin Endocrinol Metab. 82:719-724.
14. Gundberg CM, Hauschka PV, Lian JB, Gallop PM. 1984 Osteocalcin: isolation, characterization and detection. In: Moldave K, ed. Methods in enzymology, Vol. 107. New York: Academic Press; 516-544.
15. Baumgrass R, Williamson MK, Price PA. 1997 Identification of peptide fragments generated by digestion of bovine and human osteocalcin with the lysosomal proteinases cathepsin B, D, L, H, and S. J Bone Miner Res. 12:447-455.
16. Kohler G, Milstein C. 1975 Continuous cultures of fused cells secreting antibody of defined specificity. Nature. 256:495-497.
17. Power MJ, Gosling JP, Fottrell PF. 1984 Radioimmunoassay of osteocalcin with polyclonal and monoclonal antibodies. Clin Chem. 35:1408-1415.
18. Baumgrass R, Felsenberg D, Price PA. 1995 The cross-reactivities of cathepsin generated bone GLA protein-fragments in different immunoassays. J Bone Miner Res. 10:S339.
19. Diego EMD, Guerrero R, Piedra CDL. 1994 Six osteocalcin assays compared. Clin Chem. 40:2071-2077.
20. Gundberg CM, Weinstein RS. 1986 Multiple immunoreactive forms of osteocalcin in uremic serum. J Clin Invest. 77:1762-1767.
21. Blumsohn A, Hannon RA, Eastell R. 1995 Apparent instability of osteocalcin in serum as measured with different commercially available immunoassays. Clin Chem. 41:318-320.
22. Douglas AS, Robins SP, Hutchison JD, Porter RW, Stewart A, Reid DM. 1995 Carboxylation of osteocalcin in post-menopausal osteoporotic women following vitamin K and D supplementation. Bone. 17:15-20.
23. Merle B, Delmas PD. 1990 Normal carboxylation of circulating osteocalcin (bone Gla-protein) in Paget's disease of bone. Bone Miner. 11:237-245.
24. Cairns JR, Price PA. 1994 Direct demonstration that the vitamin K-dependent bone Gla protein is incompletely g-carboxylated in humans. J Bone Miner Res. 9:1989-1997.
25. Nakao M, Nishiuchi M, Nakata T, Sakakibara TKS. 1994 Synthesis of human osteocalcins: gamma-carboxyglutamic acid at position 17 is essential for a calcium-dependent conformational transition. Pept Res. 7:171-174.
26. Hauschka PVV, Wians FH. 1989 Osteocalcin-hydroxyapatite interaction in the extracellular organic matrix of bone. Anat Rec. 224:180-188.
27. Garnero P, Grimaux M, Seguin P, Delmas PD. 1994 Characterization of immunoreactive forms of human osteocalcin generated in vivo and in vitro. J Bone Miner Res. 9:255-264.
28. Chen JT, Hosoda K, Hasumi K, Ogata E, Shiraki M. 1996 Serum N-terminal osteocalcin is a good indicator for estimating responders to hormone replacement therapy in postmenopausal women. J Bone Miner Res. 11:1784-1792.
29. Gorai L, Hosoda K, Taguchi Y, et al. A heterogeneity in serum osteocalcin N-terminal fragments in Paget's disease: a comparison with other biochemical indices in pre- and post-menopause. J Bone Miner Res. 12[Suppl 1]:T678.
30. Calvo MS, Eyre DR, Gundberg CM. 1996 Molecular basis and clinical application of biological markers of bone turnover. Endocr Rev. 17:333-368.
31. Garnero P, Sornay-Rendu E, Chapuy M-C, Delmas PD. 1996 Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. J Bone Miner Res. 11:337-349.
32. Plantalech L, Guillaumont M, Vergnaud P, LeClercq M, Delmas P. 1991 Impairment of gamma carboxylation of circulating osteocalcin (Bone Gla Protein) in elderly women. J Bone Miner Res. 6:1211-1216.
33. Szulc P, Chapuy M-C, Meunier PJ, Delmas PD. 1996 Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture: a three year follow-up study. Bone. 18:487-488.